IDEAYA Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-112.96	-58.66	-49.76	-34.5	-41.98	-34.35	-11.86
Depreciation & Amortization	4.01	3.52	3.03	1.38	1.25	0.89	0.39
Share-Based Compensation	18.49	11.63	8.24	3.61	2.17	0.95	0.14
Other Operating Activities	-24.76	-43.66	-17.29	84.97	-0.75	4.89	-0.89
Operating Cash Flow	-115.22	-87.18	-55.78	55.46	-39.31	-27.62	-12.22
Capital Expenditures	-2.37	-3.44	-2.64	-0.49	-1.35	-1.71	-1.76
Change in Investments	-156.09	-29.96	-67.02	-145.75	3.62	-61.47	-7.17
Investing Cash Flow	-158.46	-33.4	-69.67	-146.24	2.27	-63.18	-8.93
Share Issuance / Repurchase	320.54	97.17	145.45	128.75	50.61	0.09	0.23
Other Financing Activities	42.18	-	-	-	-	105.29	17.26
Financing Cash Flow	362.72	97.17	145.45	128.75	50.61	105.38	17.49
Net Cash Flow	89.04	-23.41	20.01	37.97	13.56	14.58	-3.66
Free Cash Flow	-117.59	-90.62	-58.42	54.97	-40.67	-29.33	-13.98
Free Cash Flow Margin	-502.85%	-177.92%	-209.09%	281.35%	-	-	-
Free Cash Flow Per Share	-2.04	-2.19	-1.66	2.22	-3.25	-30.67	-20.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).